About UVS
UVS is a company based in Reykjavik (Iceland) founded in 1999 was acquired by deCODE Genetics in January 2006. UVS operates in a competitive market with competitors including GSK, Nanopore, Avidity Biosciences, PacBio and Sutro Biopharma, among others.
- Headquarter Reykjavik, Iceland
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Acquired by
deCODE Genetics
(Jan 18, 2006)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of UVS
Detailed funding history for UVS
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in UVS
UVS has secured backing from 1 investor. Prominent investors backing the company include deCODE Genetics.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Bioinformatics platform for genetic disease analysis is provided.
|
Locked | Locked | Locked |
Investor details for UVS
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by UVS
Investment portfolio details for UVS
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - UVS
Detailed financials for UVS
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Uvs Comparisons
Peer comparison for UVS
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of UVS
UVS operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GSK, Nanopore, Avidity Biosciences, PacBio and Sutro Biopharma, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of pharmaceuticals and vaccines for various therapeutic areas
|
|
| Locked | Locked | Locked |
Nanopore-based electronic systems for single-molecule analysis are developed.
|
|
| Locked | Locked | Locked |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| Locked | Locked | Locked |
Instrument systems and software for single-molecule real-time sequencing are developed.
|
|
| Locked | Locked | Locked |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| Locked | Locked | Locked |
Yeast cells are genetically engineered to produce medicinal products.
|
Detailed competitors of UVS
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Uvs
Complete news archive for UVS
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about UVS
UVS was founded in 1999.
UVS is headquartered in Reykjavik, Iceland.
UVS was founded in 1999 in Reykjavik, Iceland, within the biotechnology sector. Population genomic studies are employed to advance cancer research, with high-throughput sequencing methods applied to analyze the Icelandic population for inherited cancer-related genes like BRCA1 and BRCA2. Operations focus on biomarker discovery and support targeted drug development in oncology.
UVS's top competitors include Nanopore, Sutro Biopharma and Synthego.
UVS has 1 investor. Key investors include deCODE Genetics.